INSIGHTS ON DRUG DEVELOPMENT
-
Why Emerging Drug Developers Can't Afford To Delay Analytical Development
Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.
-
What Is DMPK, And Why Does It Matter In Drug Development?
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
-
Fast And Scalable Fc Quantitation In Supernatants
In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.
-
The Role Of CDMOs In Supporting Generic Drug Development
Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.
-
Are You Keeping Pace With Oligo Synthesis Optimization?11/18/2025
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Imagine The Future: An Enhanced Oligonucleotide Synthesis Process2/9/2026
Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.
-
Payload-Linker CMC Services High-Potency R&D And GMP Manufacturing6/11/2026
A closer look at how advanced containment, continuous processing, and integrated CMC workflows help address payload–linker challenges, improve safety, and enable scale-up of antibody–drug conjugates.
-
Developing High Concentration Biopharmaceuticals: Formulation Considerations9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.
DRUG DEVELOPMENT SOLUTIONS
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Explore how modern CMC approaches integrate advanced chemistry, scalable manufacturing, and strong analytics to streamline development, boost reliability, and sustain momentum to commercial supply.
-
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.
-
Unique confocal imaging solution capable of imaging more than a million wells a week
The ImageXpress® Micro Confocal system is a high-content solution that can switch between widefield and confocal imaging of fixed and live cells.
-
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.